SCHEMBL14768879

SCHEMBL14768879

C=C(NC)Nc1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.59
▸ TSHR P16473 1/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NLRP1 Q9C000 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ EPHX1 P07099 1/20 0.43
▸ PKM P14618 1/20 0.42
▸ NOX1 Q9Y5S8 1/20 0.41
▸ PDK1 Q15118 1/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ PDK3 Q15120 1/20 0.41
▸ PDK4 Q16654 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8297121 0.80 NPC1 (0.48) ALDH1A1TSHRNPC1RAB9AHTT
SCHEMBL12994851 0.80 POLB (0.50) NPC1RAB9AHTTSMN1; SMN2MAPT
SCHEMBL14258988 0.77 SMN1; SMN2 (0.48) ALDH1A1TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL20725724 0.77 ALDH1A1 (0.52) ALDH1A1TSHRNPC1RAB9AHTT
SCHEMBL14309636 0.75 ALDH1A1 (0.37) ALDH1A1TSHRNPC1RAB9AHTT
SCHEMBL22914719 0.75 NPC1 (0.49) NPC1RAB9AHTTSMN1; SMN2MAPT
SCHEMBL18902628 0.75 PEPD (0.55) ALDH1A1NPC1GAAMAPTMEN1
SCHEMBL8297116 0.74 ALDH1A1 (0.48) ALDH1A1TSHRNPC1RAB9AHTT
SCHEMBL6984302 0.74 ALDH1A1 (1.00) ALDH1A1TSHRNPC1RAB9AHTT
SCHEMBL12231564 0.74 ALDH1A1 (0.59) ALDH1A1TSHRNPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130065965-A1 DI(4-CHLORO-PHENYLDIGUANIDO) DERIVATIVE WHICH IS FREE OF POTENTIAL GENOTOXICITY AND A PROCESS FOR REDUCING THE RESIDUAL AMOUNT OF P-CHLOROANILINE IN SAID DI(4-CHLORO-PHENYLDIGUANIDO) DERIVATIVE MEDICHEM S.A. (ES) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065965-A1 DI(4-CHLORO-PHENYLDIGUANIDO) DERIVATIVE WHICH IS FREE OF POTENTIAL GENOTOXICITY AND A PROCESS FOR REDUCING THE RESIDUAL AMOUNT OF P-CHLOROANILINE IN SAID DI(4-CHLORO-PHENYLDIGUANIDO) DERIVATIVE DCTD, POLL, DDT ALDH1A1 972/4885TSHR 4238/4885NPC1 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback